Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

  • Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

BITs that bite into budgets

Date: 
Tuesday, February 26, 2013 - 10:00 to 12:00

26th February -10:00-12:00

Residence Palace, International Press Centre, Rue de la Loi 155, Brussels

Why should private lawyers reap the benefits and citizens meet the costs of claims by foreign investors? EU institutions are currently discussing international investment policy, their new competence. This offers opportunities to reform a system which has given far ranging rights to investors to challenge public policy decisions as enshrined in Bilateral Investment Treaties (BITs) between member states and third countries.

Current settlement measures allow foreign investors to bring claims against states in which they made an investment, undermining democratic decision-making and policies to protect the environment and public health. For example, Swedish energy company Vattenfall is suing Germany because of the country’s phase-out of nuclear energy. Philip Morris is suing both Australia and Uruguay for introducing compulsory health warnings on cigarette packs.

The payouts made by governments as a result of such legal claims have reached tens of billions of dollars, squeezing money out of public budgets. The Parliament and Council are currently discussing who will pay the costs when a state needs to defend itself against an investor claim under future EU treaties.

Recent research by Corporate Europe Observatory and the Transnational Institute shows that law firms and arbitrators are making millions from investment disputes against governments, actively promote new cases, and lobby against reforms that are in the public interest.

This event is an opportunity to discuss these issues and how they impact on the future of EU investment policy.

All interested members of the public and the media are cordially invited.



Programme

Inputs from civil society:
Marc Maes (11.11.11):  Introduction to the Financial Responsibility Regulation and ongoing cases/dynamics in ISDS
Pia Eberhardt (Corporate Europe Observatory):  Profiting from injustice. How law firms, arbitrators and financiers are fuelling an investment arbitration boom

Responses from MEPs, EU member states and the EU Commission:
Pawel Zalewski (MEP, EPP)
Kriton Arsenis (MEP, S&D)
Franziska Keller (MEP, Greens/EFA)
Helmut Scholz (MEP, GUE/NGL)
Etienne Oudot de Dainville (French Ministry for the Economy and Finance)
Ditte Juul-Jørgensen (EU Commission, DG Trade)

Discussion with the audience

The event will be facilitated by Jonathan Bonnitcha, London School of Economics (LSE).

 

The official EU assessment of glyphosate was based on unpublished studies owned by industry. Seven months later, the pesticide industry still fights disclosure and, so far, successfully. We obtained a copy of their arguments.

While CEO is not taking a position on the UK referendum, many of our publications are relevant to those who will have a vote, or those who are following the debate.

Biodiversity collapse, the future of agriculture, politics versus science, EU States and the European Commission shifting blame on each other, industry's capture of the regulatory process through data secrecy, a Commissioner caught between Juncker, EU States, lobby groups, and his own services... The glyphosate saga, coming to the end of its first phase tomorrow, has been an entry point into many broader problems. Overview.

The European Commission proposal on scientific criteria defining endocrine disruptors (EDCs) is the latest dangerous outgrowth of a highly toxic debate. The chemical lobby, supported by certain Commission factions (notably DG SANTE and the Secretary-General) and some member states (UK and Germany), has put significant obstacles in the way of effective public health and environment regulation.

The corporate lobby tour